Mice lacking AMP-activated protein kinase 1 catalytic subunit have increased bone remodelling and modified skeletal responses to hormonal challenges induced by ovariectomy and intermittent PTH treatment

Archive ouverte

Jeyabalan, J. | Shah, M. | Viollet, B. | Roux, P. | Chavassieux, P. | Korbonits, M. | Chenu, C.

Edité par CCSD ; BioScientifica -

International audience. AMP-activated protein kinase (AMPK) is a key regulator of cellular and body energy homeostasis. We previously demonstrated that AMPK activation in osteoblasts increases in vitro bone formation while deletion of the Ampk alpha 1 (Prkaa1) subunit, the dominant catalytic subunit expressed in bone, leads to decreased bone mass in vivo. To investigate the cause of low bone mass in the Ampk alpha 1(-/-) mice, we analysed bone formation and resorption in the tibia of these mice by dynamic histomorphometry and determined whether bone turnover can be stimulated in the absence of the Ampk alpha 1 subunit. We subjected 12-week-old Ampk alpha 1(+/+) and Ampk alpha 1(-/-) mice to ovariectomy (OVX), intermittent PTH (iPTH) administration (80 mu g/kg per day, 5 days/week) or both OVX and iPTH hormonal challenges. Tibiae were harvested from these mice and bone micro-architecture was determined by micro-computed tomography. We show for the first time that Ampk alpha 1(-/-) mice have a high bone turnover at the basal level in favour of bone resorption. While both Ampk alpha 1(+/+) and Ampk alpha 1(-/-) mice lost bone mass after OVX, the bone loss in Ampk alpha 1(-/-) mice was lower compared with controls. iPTH increased trabecular and cortical bone indexes in both ovariectomised Ampk alpha 1(+/+) and Ampk alpha 1(-/-) mice. However, ovariectomised Ampk alpha 1(-/-) mice showed a smaller increase in bone parameters in response to iPTH compared with Ampk alpha 1(+/+) mice. By contrast, non-ovariectomised Ampk alpha 1(-/-) mice responded better to iPTH treatment than non-ovariectomised Ampk alpha 1(+/+) mice. Overall, these data demonstrate that Ampk alpha 1(-/-) mice are less affected by changes in bone turnover induced by OVX but respond better to the anabolic challenge induced by iPTH. These results suggest that AMPK alpha 1 activation may play a role in the hormonal regulation of bone remodelling. Journal of Endocrinology (2012) 214, 349-358

Consulter en ligne

Suggestions

Du même auteur

The anti-diabetic drug metformin does not affect bone mass in vivo or fracture healing

Archive ouverte | Jeyabalan, J. | CCSD

WOS:000324536200013. International audience. The present study shows no adverse effects of the anti-diabetic drug metformin on bone mass and fracture healing in rodents but demonstrates that metformin is not osteoge...

Excessive Growth Hormone Expression in Male GH Transgenic Mice Adversely Alters Bone Architecture and Mechanical Strength

Archive ouverte | Lim, S. V. | CCSD

WOS:000353272700017. International audience. Patients with acromegaly have a higher prevalence of vertebral fractures despite normal bone mineral density (BMD), suggesting that GH overexpression has adverse effects ...

Chronic administration of Glucagon-like peptide-1 receptor agonists improves trabecular bone mass and architecture in ovariectomised mice

Archive ouverte | Pereira, M. | CCSD

WOS:000365372800056. International audience. Some anti-diabetic therapies can have adverse effects on bone health and increase fracture risk. In this study, we tested the skeletal effects of chronic administration o...

Chargement des enrichissements...